These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38968945)

  • 21. The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein.
    El Kasmi KC; Theisen D; Brons NH; Muller CP
    Mol Immunol; 1998 Oct; 35(14-15):905-18. PubMed ID: 9881686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation.
    Taylor H; Wall W; Ross D; Janarthanan R; Wang L; Aiano F; Ellis J; Gopal R; Andrews N; Patel M; Lackenby A; Myers R; Ramsay ME; Chow JY; Zambon M; Ladhani SN
    Lancet Reg Health Eur; 2021 Mar; 2():100015. PubMed ID: 33870245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of important antibodies for kidney disease: pre-analytic methodological considerations.
    Han Q; Li S; Fu B; Liu D; Wu M; Yang X; Cai G; Liu Z; Chen X; Zhu H
    PeerJ; 2018; 6():e5178. PubMed ID: 30013843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans.
    Morokutti A; Muster T; Ferko B
    Vaccine; 2014 Apr; 32(17):1897-900. PubMed ID: 24560674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Mokola virus neutralising antibodies in Nigerian dogs.
    Aghomo HO; Tomori O; Oduye OO; Rupprecht CE
    Res Vet Sci; 1990 Mar; 48(2):264. PubMed ID: 2333438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of antibodies to Crimean Congo haemorrhagic fever virus in sheep in Tunisia, North Africa.
    Khamassi Khbou M; Romdhane R; Bouaicha Zaafouri F; Bouajila M; Sassi L; Appelberg SK; Schulz A; Mirazimi A; Groschup MH; Rekik M; Benzarti M; Gharbi M
    Vet Med Sci; 2021 Nov; 7(6):2323-2329. PubMed ID: 34390548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitope mapping of neutralising anti-SARS-CoV-2 monoclonal antibodies: Implications for immunotherapy and vaccine design.
    Ghotloo S; Maghsood F; Golsaz-Shirazi F; Amiri MM; Moog C; Shokri F
    Rev Med Virol; 2022 Sep; 32(5):e2347. PubMed ID: 35394093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015.
    Palomar AM; Portillo A; Santibáñez S; García-Álvarez L; Muñoz-Sanz A; Márquez FJ; Romero L; Eiros JM; Oteo JA
    Enferm Infecc Microbiol Clin; 2017; 35(6):344-347. PubMed ID: 28291670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application.
    Hargreaves A; Brady C; Mellors J; Tipton T; Carroll MW; Longet S
    Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies.
    Müller K; Girl P; Giebl A; Gruetzner S; Antwerpen M; Khatamzas E; Wölfel R; von Buttlar H
    Virus Genes; 2021 Dec; 57(6):502-509. PubMed ID: 34608598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of anti-drug antibodies in human serum samples.
    Solberg H; Bartholdy C; Landsy LH; Andresen LO
    J Immunol Methods; 2024 Feb; 525():113616. PubMed ID: 38211695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can Zika virus antibodies cross-protect against dengue virus? - Authors' reply.
    Ribeiro GS; Kikuti M; Tauro LB; Cardoso CW; Paploski IA; Ko AI; Weaver SC; Reis MG; Kitron U
    Lancet Glob Health; 2018 May; 6(5):e495. PubMed ID: 29653620
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term persistence of neutralising antibodies against bluetongue virus serotype 8 in naturally infected cattle.
    Eschbaumer M; Eschweiler J; Hoffmann B
    Vaccine; 2012 Nov; 30(50):7142-3. PubMed ID: 22940291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.
    Hirsch C; Park YS; Piechotta V; Chai KL; Estcourt LJ; Monsef I; Salomon S; Wood EM; So-Osman C; McQuilten Z; Spinner CD; Malin JJ; Stegemann M; Skoetz N; Kreuzberger N
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD014945. PubMed ID: 35713300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and control of Menangle virus in pigs.
    Kirkland PD; Love RJ; Philbey AW; Ross AD; Davis RJ; Hart KG
    Aust Vet J; 2001 Mar; 79(3):199-206. PubMed ID: 11301749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient generation of vesicular stomatitis virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies.
    Logan N; McMonagle E; Drew AA; Takahashi E; McDonald M; Baron MD; Gilbert M; Cleaveland S; Haydon DT; Hosie MJ; Willett BJ
    Vaccine; 2016 Feb; 34(6):814-22. PubMed ID: 26706278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candidates for reference swine serum with anti-Trichinella antibodies.
    Gómez-Morales MA; Ludovisi A; Amati M; Pozio E
    Vet Parasitol; 2015 Mar; 208(3-4):218-24. PubMed ID: 25659658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equine rhinitis A virus-like particle expressing DNA vaccine induces a virus neutralising immune response in mice.
    Lynch SE; Gilkerson JR; Symes SJ; Huang JA; Tatarczuch L; Hartley CA
    Virus Res; 2011 Jun; 158(1-2):294-7. PubMed ID: 21539868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of benzalkonium surfactants on hemimicelle-based solid-phase extraction cartridges.
    Luque N; Merino F; Rubio S; Pérez-Bendito D
    J Chromatogr A; 2005 Nov; 1094(1-2):17-23. PubMed ID: 16257284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α.
    Mathian A; Breillat P; Dorgham K; Bastard P; Charre C; Lhote R; Quentric P; Moyon Q; Mariaggi AA; Mouries-Martin S; Mellot C; Anna F; Haroche J; Cohen-Aubart F; Sterlin D; Zahr N; Gervais A; Le Voyer T; Bizien L; Amiot Q; Pha M; Hié M; Chasset F; Yssel H; Miyara M; Charneau P; Ghillani-Dalbin P; Casanova JL; Rozenberg F; Amoura Z; Gorochov G
    Ann Rheum Dis; 2022 Dec; 81(12):1695-1703. PubMed ID: 35973806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.